ID   AT2A2_RAT               Reviewed;        1043 AA.
AC   P11507; P11508;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   02-OCT-2024, entry version 212.
DE   RecName: Full=Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;
DE            Short=SERCA2;
DE            Short=SR Ca(2+)-ATPase 2;
DE            EC=7.2.2.10;
DE   AltName: Full=Calcium pump 2;
DE   AltName: Full=Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform;
DE   AltName: Full=Endoplasmic reticulum class 1/2 Ca(2+) ATPase;
GN   Name=Atp2a2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=2844797; DOI=10.1016/s0021-9258(18)68142-6;
RA   Gunteski-Hamblin A.-M., Greeb J., Shull G.E.;
RT   "A novel Ca2+ pump expressed in brain, kidney, and stomach is encoded by an
RT   alternative transcript of the slow-twitch muscle sarcoplasmic reticulum Ca-
RT   ATPase gene. Identification of cDNAs encoding Ca2+ and other cation-
RT   transporting ATPases using an oligonucleotide probe derived from the ATP-
RT   binding site.";
RL   J. Biol. Chem. 263:15032-15040(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=2542094; DOI=10.1016/0014-5793(89)80010-9;
RA   Lompre A.M., de la Bastie D., Boheler K.R., Schwartz K.;
RT   "Characterization and expression of the rat heart sarcoplasmic reticulum
RT   Ca2+-ATPase mRNA.";
RL   FEBS Lett. 249:35-41(1989).
RN   [3]
RP   NITRATION AT TYR-294 AND TYR-295.
RX   PubMed=10359649; DOI=10.1042/bj3400657;
RA   Viner R.I., Ferrington D.A., Williams T.D., Bigelow D.J., Schoeneich C.;
RT   "Protein modification during biological aging: selective tyrosine nitration
RT   of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in
RT   skeletal muscle.";
RL   Biochem. J. 340:657-669(1999).
RN   [4]
RP   NITRATION AT TYR-294 AND TYR-295.
RX   PubMed=16399855; DOI=10.1152/ajpheart.01293.2005;
RA   Xu S., Ying J., Jiang B., Guo W., Adachi T., Sharov V., Lazar H.,
RA   Menzoian J., Knyushko T.V., Bigelow D., Schoeneich C., Cohen R.A.;
RT   "Detection of sequence-specific tyrosine nitration of manganese SOD and
RT   SERCA in cardiovascular disease and aging.";
RL   Am. J. Physiol. 290:H2220-H2227(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38; SER-661 AND SER-663, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of
CC       ATP coupled with the translocation of calcium from the cytosol to the
CC       sarcoplasmic reticulum lumen. Involved in autophagy in response to
CC       starvation. Upon interaction with VMP1 and activation, controls ER-
CC       isolation membrane contacts for autophagosome formation. Also modulates
CC       ER contacts with lipid droplets, mitochondria and endosomes (By
CC       similarity). In coordination with FLVCR2 mediates heme-stimulated
CC       switching from mitochondrial ATP synthesis to thermogenesis (By
CC       similarity). {ECO:0000250|UniProtKB:O55143,
CC       ECO:0000250|UniProtKB:P16615}.
CC   -!- FUNCTION: [Isoform 2]: Involved in the regulation of the
CC       contraction/relaxation cycle. Acts as a regulator of TNFSF11-mediated
CC       Ca(2+) signaling pathways via its interaction with TMEM64 which is
CC       critical for the TNFSF11-induced CREB1 activation and mitochondrial ROS
CC       generation necessary for proper osteoclast generation. Association
CC       between TMEM64 and SERCA2 in the ER leads to cytosolic Ca(2+) spiking
CC       for activation of NFATC1 and production of mitochondrial ROS, thereby
CC       triggering Ca(2+) signaling cascades that promote osteoclast
CC       differentiation and activation. {ECO:0000250|UniProtKB:O55143}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + Ca(2+)(in) + H2O = ADP + Ca(2+)(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:18105, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29108, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:456216; EC=7.2.2.10;
CC         Evidence={ECO:0000250|UniProtKB:P16615};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18106;
CC         Evidence={ECO:0000250|UniProtKB:P16615};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P11607};
CC   -!- ACTIVITY REGULATION: Has different conformational states with
CC       differential Ca2+ affinity. The E1 conformational state (active form)
CC       shows high Ca(2+) affinity, while the E2 state exhibits low Ca(2+)
CC       affinity. Reversibly inhibited by phospholamban (PLN) at low calcium
CC       concentrations. Inhibited by sarcolipin (SLN) and myoregulin (MRLN).
CC       The inhibition is blocked by VMP1 (By similarity). Enhanced by DWORF;
CC       DWORF increases activity by displacing sarcolipin (SLN), phospholamban
CC       (PLN) and myoregulin (MRLN) (By similarity). Stabilizes SERCA2 in its
CC       E2 state (By similarity). {ECO:0000250|UniProtKB:O55143,
CC       ECO:0000250|UniProtKB:P04191, ECO:0000250|UniProtKB:P16615,
CC       ECO:0000250|UniProtKB:Q8R429}.
CC   -!- SUBUNIT: Interacts with sarcolipin (SLN); the interaction inhibits
CC       ATP2A2 Ca(2+) affinity. Interacts with phospholamban (PLN); the
CC       interaction inhibits ATP2A2 Ca(2+) affinity (By similarity). Interacts
CC       with myoregulin (MRLN) (By similarity). Interacts with DWORF (By
CC       similarity). Interacts with HAX1 (By similarity). Interacts with S100A8
CC       and S100A9 (By similarity). Interacts with SLC35G1 and STIM1. Interacts
CC       with TMEM203 (By similarity). Interacts with TMEM64 and PDIA3 (By
CC       similarity). Interacts with TMX1 (By similarity). Interacts with TMX2
CC       (By similarity). Interacts with VMP1; VMP1 competes with PLN and SLN to
CC       prevent them from forming an inhibitory complex with ATP2A2. Interacts
CC       with ULK1 (By similarity). Interacts with S100A1 in a Ca(2+)-dependent
CC       manner (By similarity). Interacts with TUNAR (By similarity). Interacts
CC       with FLVCR2; this interaction occurs in the absence of heme and
CC       promotes ATP2A2 proteasomal degradation; this complex is dissociated
CC       upon heme binding. Interacts with FNIP1. {ECO:0000250|UniProtKB:O55143,
CC       ECO:0000250|UniProtKB:P04191, ECO:0000250|UniProtKB:P16615,
CC       ECO:0000250|UniProtKB:Q8R429}.
CC   -!- SUBUNIT: [Isoform 1]: Interacts with TRAM2 (via C-terminus).
CC       {ECO:0000250|UniProtKB:P16615}.
CC   -!- INTERACTION:
CC       P11507; Q9EQU3: Tlr9; Xeno; NbExp=4; IntAct=EBI-916319, EBI-9979528;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:O55143}; Multi-pass membrane protein
CC       {ECO:0000255}. Sarcoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:O55143}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Colocalizes with FLVCR2 at the mitochondrial-ER
CC       contact junction. {ECO:0000250|UniProtKB:O55143}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Atp2a2b, SERCA2b;
CC         IsoId=P11507-1; Sequence=Displayed;
CC       Name=2; Synonyms=Atp2a2a, SERCA2a;
CC         IsoId=P11507-2; Sequence=VSP_000362;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is highly expressed in heart and slow
CC       twitch skeletal muscle. Isoform 1 is widely expressed.
CC   -!- DOMAIN: Ca(2+) and ATP binding cause major rearrangements of the
CC       cytoplasmic and transmembrane domains. According to the E1-E2 model,
CC       Ca(2+) binding to the cytosolic domain of the pump in the high-affinity
CC       E1 conformation is followed by the ATP-dependent phosphorylation of the
CC       active site Asp, giving rise to E1P. A conformational change of the
CC       phosphoenzyme gives rise to the low-affinity E2P state that exposes the
CC       Ca(2+) ions to the lumenal side and promotes Ca(2+) release.
CC       Dephosphorylation of the active site Asp mediates the subsequent return
CC       to the E1 conformation. {ECO:0000250|UniProtKB:P04191}.
CC   -!- DOMAIN: PLN and SLN both have a single transmembrane helix; both occupy
CC       a similar binding site that is situated between the ATP2A2
CC       transmembrane helices. {ECO:0000250|UniProtKB:P04191}.
CC   -!- PTM: Nitrated under oxidative stress. Nitration on the two tyrosine
CC       residues inhibits catalytic activity. {ECO:0000250|UniProtKB:P16615}.
CC   -!- PTM: Serotonylated on Gln residues by TGM2 in response to hypoxia,
CC       leading to its inactivation. {ECO:0000250|UniProtKB:O55143}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IIA subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04022; AAA40785.1; -; mRNA.
DR   EMBL; J04024; AAA40787.1; -; mRNA.
DR   EMBL; J04023; AAA40786.1; -; mRNA.
DR   EMBL; X15635; CAA33645.1; -; mRNA.
DR   PIR; A31982; A31982.
DR   PIR; B31982; B31982.
DR   RefSeq; NP_001103609.1; NM_001110139.2. [P11507-2]
DR   RefSeq; NP_001104293.1; NM_001110823.2. [P11507-1]
DR   AlphaFoldDB; P11507; -.
DR   SMR; P11507; -.
DR   BioGRID; 248313; 6.
DR   CORUM; P11507; -.
DR   IntAct; P11507; 9.
DR   MINT; P11507; -.
DR   STRING; 10116.ENSRNOP00000024347; -.
DR   BindingDB; P11507; -.
DR   ChEMBL; CHEMBL3585237; -.
DR   DrugCentral; P11507; -.
DR   CarbonylDB; P11507; -.
DR   GlyGen; P11507; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P11507; -.
DR   PhosphoSitePlus; P11507; -.
DR   jPOST; P11507; -.
DR   PaxDb; 10116-ENSRNOP00000024347; -.
DR   PeptideAtlas; P11507; -.
DR   Ensembl; ENSRNOT00000001738.8; ENSRNOP00000001738.7; ENSRNOG00000001285.9. [P11507-1]
DR   Ensembl; ENSRNOT00055026015; ENSRNOP00055021197; ENSRNOG00055015092. [P11507-1]
DR   Ensembl; ENSRNOT00060003502; ENSRNOP00060002394; ENSRNOG00060002173. [P11507-1]
DR   Ensembl; ENSRNOT00065010948; ENSRNOP00065008043; ENSRNOG00065006868. [P11507-1]
DR   GeneID; 29693; -.
DR   KEGG; rno:29693; -.
DR   UCSC; RGD:2174; rat. [P11507-1]
DR   AGR; RGD:2174; -.
DR   CTD; 488; -.
DR   RGD; 2174; Atp2a2.
DR   eggNOG; KOG0202; Eukaryota.
DR   GeneTree; ENSGT00940000159986; -.
DR   InParanoid; P11507; -.
DR   OrthoDB; 203629at2759; -.
DR   PhylomeDB; P11507; -.
DR   Reactome; R-RNO-418359; Reduction of cytosolic Ca++ levels.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-936837; Ion transport by P-type ATPases.
DR   PRO; PR:P11507; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001285; Expressed in heart and 19 other cell types or tissues.
DR   GO; GO:0061831; C:apical ectoplasmic specialization; IDA:RGD.
DR   GO; GO:0090534; C:calcium ion-transporting ATPase complex; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:RGD.
DR   GO; GO:0014801; C:longitudinal sarcoplasmic reticulum; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0120025; C:plasma membrane bounded cell projection; IDA:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0097470; C:ribbon synapse; ISO:RGD.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:RGD.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0106222; F:lncRNA binding; ISO:RGD.
DR   GO; GO:0031775; F:lutropin-choriogonadotropic hormone receptor binding; IPI:RGD.
DR   GO; GO:0005388; F:P-type calcium transporter activity; IDA:BHF-UCL.
DR   GO; GO:0086039; F:P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential; ISS:UniProtKB.
DR   GO; GO:0044548; F:S100 protein binding; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0000045; P:autophagosome assembly; ISS:UniProtKB.
DR   GO; GO:0016240; P:autophagosome membrane docking; ISS:UniProtKB.
DR   GO; GO:1990036; P:calcium ion import into sarcoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0006816; P:calcium ion transport; IDA:RGD.
DR   GO; GO:1903515; P:calcium ion transport from cytosol to endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0014898; P:cardiac muscle hypertrophy in response to stress; ISO:RGD.
DR   GO; GO:0034605; P:cellular response to heat; IEP:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0006984; P:ER-nucleus signaling pathway; ISO:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:1990456; P:mitochondrion-endoplasmic reticulum membrane tethering; ISS:UniProtKB.
DR   GO; GO:0045822; P:negative regulation of heart contraction; ISO:RGD.
DR   GO; GO:0070050; P:neuron cellular homeostasis; ISO:RGD.
DR   GO; GO:0140056; P:organelle localization by membrane tethering; ISS:UniProtKB.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:0032470; P:positive regulation of endoplasmic reticulum calcium ion concentration; ISO:RGD.
DR   GO; GO:1903233; P:regulation of calcium ion-dependent exocytosis of neurotransmitter; ISO:RGD.
DR   GO; GO:0098909; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; IDA:BHF-UCL.
DR   GO; GO:0086036; P:regulation of cardiac muscle cell membrane potential; IDA:BHF-UCL.
DR   GO; GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; IDA:BHF-UCL.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; ISO:RGD.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; IDA:BHF-UCL.
DR   GO; GO:0090076; P:relaxation of skeletal muscle; IEP:RGD.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IEP:ParkinsonsUK-UCL.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IDA:UniProtKB.
DR   GO; GO:0070296; P:sarcoplasmic reticulum calcium ion transport; IDA:RGD.
DR   GO; GO:0033292; P:T-tubule organization; ISO:RGD.
DR   GO; GO:0014883; P:transition between fast and slow fiber; ISO:RGD.
DR   CDD; cd02083; P-type_ATPase_SERCA; 1.
DR   Gene3D; 3.40.1110.10; Calcium-transporting ATPase, cytoplasmic domain N; 1.
DR   Gene3D; 2.70.150.10; Calcium-transporting ATPase, cytoplasmic transduction domain A; 1.
DR   Gene3D; 1.20.1110.10; Calcium-transporting ATPase, transmembrane domain; 1.
DR   Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR005782; P-type_ATPase_IIA.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   NCBIfam; TIGR01116; ATPase-IIA1_Ca; 1.
DR   NCBIfam; TIGR01494; ATPase_P-type; 2.
DR   PANTHER; PTHR42861; CALCIUM-TRANSPORTING ATPASE; 1.
DR   PANTHER; PTHR42861:SF18; SARCOPLASMIC_ENDOPLASMIC RETICULUM CALCIUM ATPASE 2; 1.
DR   Pfam; PF13246; Cation_ATPase; 1.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   Pfam; PF00702; Hydrolase; 1.
DR   PRINTS; PR00119; CATATPASE.
DR   PRINTS; PR00120; HATPASE.
DR   SFLD; SFLDS00003; Haloacid_Dehalogenase; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF81653; Calcium ATPase, transduction domain A; 1.
DR   SUPFAM; SSF81665; Calcium ATPase, transmembrane domain M; 1.
DR   SUPFAM; SSF56784; HAD-like; 1.
DR   SUPFAM; SSF81660; Metal cation-transporting ATPase, ATP-binding domain N; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Calcium transport;
KW   Disulfide bond; Endoplasmic reticulum; Ion transport; Magnesium; Membrane;
KW   Metal-binding; Nitration; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Sarcoplasmic reticulum; Translocase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..1043
FT                   /note="Sarcoplasmic/endoplasmic reticulum calcium ATPase 2"
FT                   /id="PRO_0000046200"
FT   TOPO_DOM        1..48
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        49..69
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        70..89
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        90..110
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        111..253
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        254..273
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        274..295
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        296..313
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        314..756
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        757..776
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        777..786
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        787..807
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        808..827
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        828..850
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        851..896
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        897..916
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        917..929
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        930..948
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        949..963
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        964..984
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   TOPO_DOM        985..1043
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          575..594
FT                   /note="Interaction with HAX1"
FT                   /evidence="ECO:0000250"
FT   REGION          787..807
FT                   /note="Interaction with PLN"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   REGION          788..1043
FT                   /note="Interaction with TMEM64 and PDIA3"
FT                   /evidence="ECO:0000250|UniProtKB:O55143"
FT   REGION          931..942
FT                   /note="Interaction with PLN"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   ACT_SITE        351
FT                   /note="4-aspartylphosphate intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   BINDING         304
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         305
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         307
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         309
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         351
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         353
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         353
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         442
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         489
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         514
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         559
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   BINDING         624
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   BINDING         625
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   BINDING         626
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         677
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         683
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   BINDING         702
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         705
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         767
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         770
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         795
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         798
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         799
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         799
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   BINDING         907
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P04191"
FT   MOD_RES         38
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         294
FT                   /note="3'-nitrotyrosine"
FT                   /evidence="ECO:0000269|PubMed:10359649,
FT                   ECO:0000269|PubMed:16399855"
FT   MOD_RES         295
FT                   /note="3'-nitrotyrosine"
FT                   /evidence="ECO:0000269|PubMed:10359649,
FT                   ECO:0000269|PubMed:16399855"
FT   MOD_RES         441
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64578"
FT   MOD_RES         531
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55143"
FT   MOD_RES         580
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P16615"
FT   MOD_RES         661
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         663
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   DISULFID        875..887
FT                   /evidence="ECO:0000250|UniProtKB:P11607"
FT   VAR_SEQ         994..1043
FT                   /note="GKECAQPATKPSCSLSACTDGISWPFVLLIMPLVVWVYSTDTNFSDMFWS
FT                   -> AILE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:2542094,
FT                   ECO:0000303|PubMed:2844797"
FT                   /id="VSP_000362"
SQ   SEQUENCE   1043 AA;  114768 MW;  4B0B476BFD97F390 CRC64;
     MENAHTKTVE EVLGHFGVNE STGLSLEQVK KLKERWGSNE LPAEEGKTLL ELVIEQFEDL
     LVRILLLAAC ISFVLAWFEE GEETITAFVE PFVILLILVA NAIVGVWQER NAENAIEALK
     EYEPEMGKVY RQDRKSVQRI KAKDIVPGDI VEIAVGDKVP ADIRLTSIKS TTLRVDQSIL
     TGESVSVIKH TDPVPDPRAV NQDKKNMLFS GTNIAAGKAM GVVVATGVNT EIGKIRDEMV
     ATEQERTPLQ QKLDEFGEQL SKVISLICIA VWIINIGHFN DPVHGGSWIR GAIYYFKIAV
     ALAVAAIPEG LPAVITTCLA LGTRRMAKKN AIVRSLPSVE TLGCTSVICS DKTGTLTTNQ
     MSVCRMFILD KVEGDTCSLN EFTITGSTYA PIGEVQKDDK PVKCHQYDGL VELATICALC
     NDSALDYNEA KGVYEKVGEA TETALTCLVE KMNVFDTELK GLSKIERANA CNSVIKQLMK
     KEFTLEFSRD RKSMSVYCTP NKPSRTSMSK MFVKGAPEGV IDRCTHIRVG STKVPMTPGV
     KQKIMSVIRE WGSGSDTLRC LALATHDNPL RREEMHLEDS ANFIKYETNL TFVGCVGMLD
     PPRIEVASSV KLCRQAGIRV IMITGDNKGT AVAICRRIGI FGQDEDVTSK AFTGREFDEL
     SPSAQRDACL NARCFARVEP SHKSKIVEFL QSFDEITAMT GDGVNDAPAL KKSEIGIAMG
     SGTAVAKTAS EMVLADDNFS TIVAAVEEGR AIYNNMKQFI RYLISSNVGE VVCIFLTAAL
     GFPEALIPVQ LLWVNLVTDG LPATALGFNP PDLDIMNKPP RNPKEPLISG WLFFRYLAIG
     CYVGAATVGA AAWWFIAADG GPRVSFYQLS HFLQCKEDNP DFEGVDCAIF ESPYPMTMAL
     SVLVTIEMCN ALNSLSENQS LLRMPPWENI WLVGSICLSM SLHFLILYVE PLPLIFQITP
     LNLTQWLMVL KISLPVILMD ETLKFVARNY LEPGKECAQP ATKPSCSLSA CTDGISWPFV
     LLIMPLVVWV YSTDTNFSDM FWS
//
